Exhaled breath condensate: 8-isoprostane and eicosanoids

P. Montuschi

Source: Eur Respir Monogr 2010; 49: 196-206
Journal Issue: Exhaled Biomarkers
Disease area: Airway diseases

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Montuschi. Exhaled breath condensate: 8-isoprostane and eicosanoids. Eur Respir Monogr 2010; 49: 196-206

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007



Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
Source: Eur Respir J 2002; 20: 1393-1398
Year: 2002



Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004

Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006



Cysteinyl leukotrienes in exhaled breath condensate in children: noninvasive marker of remodeling?
Source: Eur Respir J 2003; 22: Suppl. 45, 397s
Year: 2003

Inflammatory mediators in exhaled breath condensate, induced sputum and saliva
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004

Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010

Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Saliva is one likely source of leukotriene B4 in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1229-1235
Year: 2006



Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011


Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003

Correlation of LTB4 with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

Validation of assays for inflammatory mediators in exhaled breath condensate
Source: Eur Respir J 2008; 31: 943-948
Year: 2008



Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002